• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

中国药物评价 ›› 2023, Vol. 40 ›› Issue (4): 300-304.

• 评价技术与方法 • 上一篇    下一篇

盐酸伊立替康脂质体注射液释放度前处理方法(分离条件)研究

孙婷婷, 孙春艳, 王德国, 江茶龙, 吕慧敏*   

  1. 扬子江药业集团有限公司, 江苏 泰州 225300
  • 收稿日期:2023-06-30 修回日期:2023-07-26 出版日期:2023-08-28 发布日期:2023-08-28

The Research on the Pretreatment Method of the Release in Vitro of Irinotecan Hydrochloride Liposome Injection

  1. Yangtze River Pharmaceutical Group, Jiangsu Taizhou 225300, China
  • Received:2023-06-30 Revised:2023-07-26 Online:2023-08-28 Published:2023-08-28

摘要: 目的:采用葡聚糖凝胶柱色谱法对盐酸伊立替康脂质体注射液体外释放率前处理方法(分离条件)进行研究。方法:考察不同粒径(G25、G50)葡聚糖凝胶、葡聚糖凝胶溶胀时间、凝胶柱填充高度、柱子预处理、分离游离药物和脂质体的洗脱剂种类以及洗脱剂体积对样品脂质体的分离效果,以柱回收率和释放结果为综合指标筛选分离脂质体基质与释放游离药物的最优条件。结果:G50粒径的葡聚糖凝胶对样品分离效果更好、优选分离条件为葡聚糖凝胶溶胀时间至少2 h、凝胶柱内径为2.8~3.2 cm、柱子预处理方式为5%葡萄糖(200 μL)2 600 r·min-1离心2 min、内相(A相)洗脱剂为5%葡萄糖溶液、外相(B相)洗脱剂为3%三乙胺(pH 3.5)-乙腈(77∶23)溶液。结论:所建立的盐酸伊立替康脂质体体外释放率样品前处理(分离条件)方法重现性、柱回收率良好。

关键词: font-size:medium, ">盐酸伊立替康脂质体;葡聚糖凝胶;柱回收率;体外释放率

Abstract: Objective: To study the method of the pretreatment of the separation condition of the release in vitro of irinotecan hydrochloride liposome injection by using Sephadex Gel Column Chromatography. Methods: The separation effect of different particle sizes (G25, G50), the swelling time of Sephadex gel,the pretreatment method of Sephadex gel column,the type and volume of the eluent influenced the separating of free drug from liposomes was investigated. With the column recovery and the release in vitro results as index,the optimal condition for the seperation of the release free drug and the liposome was selected. Results: Sephadex G50 had better separation effect on samples. The preferred determination conditions were that the swelling time of Sephadex gel was at least 2 hours, the inner diameter of Sephadex gel column was 2.8-3.2 cm. The pretreatment method of Sephadex gel column was to centrifuge with 5% glucose solution for 2 minutes that a centrifugal speed up to 2 600 r·min-1. The internal phase (A phase)eluent was 5% glucose solution,and the external phase (B phase) eluent was 3% triethylamine (pH 3.5)-acetonitrile (77∶23) solution. Conclusion: The established method for the pretreatment of the separation condition of the release in vitro of irinotecan hydrochloride liposome has good reproducibility and column recovery.

Key words: font-size:medium, ">Rinotecan hydrochloride liposome; Sephadex gel; The column recovery;The release in vitro

中图分类号: